Particle beam – proton,neutron & heavy ion therapyAswathi c p
particle therapy is advanced external beam therapy used to treat cancer , which uses beams of protons or other charged particles such as helium, carbon or other ions instead of photons. charged particles have different depth-dose distributions compared to photons. They deposit most of their energy in the last final millimeters of their trajectory (when their speed slows). This results in a sharp and localized peak of dose, known as the Bragg peak.
This seminar is presented as a part of weekly journal club and seminar regularly conducted at Apollo hospital,Kolkata Department of Radiation oncology.
IORT uses a high single-fraction radiation dose (10-30 Gy) is delivered during surgery to a surgically-exposed tumour bed, immediately after a chunk of the tumour has been surgically excised. This slide includes topics like APBI, IOERT, IOHDR.
Particle beam – proton,neutron & heavy ion therapyAswathi c p
particle therapy is advanced external beam therapy used to treat cancer , which uses beams of protons or other charged particles such as helium, carbon or other ions instead of photons. charged particles have different depth-dose distributions compared to photons. They deposit most of their energy in the last final millimeters of their trajectory (when their speed slows). This results in a sharp and localized peak of dose, known as the Bragg peak.
This seminar is presented as a part of weekly journal club and seminar regularly conducted at Apollo hospital,Kolkata Department of Radiation oncology.
IORT uses a high single-fraction radiation dose (10-30 Gy) is delivered during surgery to a surgically-exposed tumour bed, immediately after a chunk of the tumour has been surgically excised. This slide includes topics like APBI, IOERT, IOHDR.
Mind the Gap: Dealing with Interruptions in Radiotherapy TreatmentVictor Ekpo
A review of guidance on compensatory steps to take due to unscheduled interruptions in patient radiotherapy treatment, due to patient illness, staff illness or machine breakdown.
Interruptions are quite often. Different centres in different literature have quoted from 6 up to 63% of patients experience interruption. To reduce the risk of cancer recurrence, the Medical Physicist needs to calculate and determine compensatory action in dose, number of fraction or other action required.
A review of advances in Brachytherapy treatment planning and delivery in last decade or so, with main focus on brachytherapy for Prostate cancer, Breast cancer and Cervical cancer
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEXVictor Ekpo
TPR(20,10) is the recommended photon beam quality index by IAEA TRS-398 for megavoltage clinical photons generated by linear accelerators. This presentation goes through the basics of Tissue Phantom Ratio (TPR).
A summary of recent innovations in radiation oncology focussing on the priniciples of different techniques and their application. An overview of clinical results has also been given
Mind the Gap: Dealing with Interruptions in Radiotherapy TreatmentVictor Ekpo
A review of guidance on compensatory steps to take due to unscheduled interruptions in patient radiotherapy treatment, due to patient illness, staff illness or machine breakdown.
Interruptions are quite often. Different centres in different literature have quoted from 6 up to 63% of patients experience interruption. To reduce the risk of cancer recurrence, the Medical Physicist needs to calculate and determine compensatory action in dose, number of fraction or other action required.
A review of advances in Brachytherapy treatment planning and delivery in last decade or so, with main focus on brachytherapy for Prostate cancer, Breast cancer and Cervical cancer
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEXVictor Ekpo
TPR(20,10) is the recommended photon beam quality index by IAEA TRS-398 for megavoltage clinical photons generated by linear accelerators. This presentation goes through the basics of Tissue Phantom Ratio (TPR).
A summary of recent innovations in radiation oncology focussing on the priniciples of different techniques and their application. An overview of clinical results has also been given
A primer of oncology basics for nursing students. Includes basic oncology, understanding cancer and understanding radiation therapy in an easy to comprehend manner.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
1. Radiation Therapy
Rays of Hope
The Past , The Present & The Future
Lokesh Viswanath M.D
Professor & Head of Unit II , Radiation Oncology,
Kidwai Memorial Institute of Oncology
2015
3. Definition of Radiation Oncology
• discipline of human medicine concerned with the
generation, conservation, and dissemination of
knowledge concerning the causes, prevention, and
treatment of cancer and other diseases involving
special expertise in the therapeutic applications of
ionizing radiation.
• radiation oncology is concerned with the investigation
of the fundamental principles of cancer biology, the
biologic interaction of radiation with normal and
malignant tissue, and the physical basis of therapeutic
radiation.
• As a learned profession, radiation oncology is
concerned with clinical care, scientific research, and
the education of professionals within the discipline.
5. The aim of radiation therapy
• to deliver a precisely measured dose of
radiation to a defined tumor volume with as
minimal damage as possible to surrounding
healthy tissue, resulting in eradication of the
tumor, a high quality of life, and prolongation
of survival at competitive cost.
6. • under our care we take full and exclusive responsibility,
exactly as does the surgeon who takes care of a patient
with cancer.
• This means that we examine the patient personally, review
the microscopic material, perform examinations and take a
biopsy if necessary.
• On the basis of this thorough clinical investigation we
consider the plan of treatment and suggest it to the
referring physician and to the patient.
• We reserve for ourselves the right to an independent
opinion regarding diagnosis and advisable therapy and if
necessary, the right of disagreement with the referring
physician.
• During the course of treatment, we ourselves direct any
additional medication that may be necessary and are ready
to be called in an emergency at any time.
9. ELECTROMAGNETIC RADIATIONS
Photon E = h(energy = Planck’s const x frequency)
= hc/ (c = speed of light, = wave length)
10-9 10-8 10-7 10-6 10-5 10-4 10-3 10-2 10-1 1 10 102 103 104
rays
X-rays U.V.
v
i
s
i
b
l
e
Infra Red Radio Waves
Microwaves Short Waves
T.V.
Radio
Radar
IONIZING
RADIATION NON-IONIZING RADIATION
(cms)
E (eV) 1.24x107 1.24x102 1.24x10-13
10. Incandescent Light
Bulbs
Diagnostic
X Ray tube
Voltage of a Lightning Bolt
110-240 Volts 80-140Kilo Volts 3 to 120 million volts
Telecobalt Machine Linear Accelerator
1.1 Mv (Mega =
Million Volts)
Low Energy - 4-6 MV
High Energy - 18 Mv
6 Million Volts
18 Million Volts
11. Introduction
• Basics of Radiation Therapy
– High energy Ionizing Radiation – X / γ Rays
– Interaction of Radiation with matter
Transmission Attenuation
Scatter Absorption
Rad / Gray / cGy
12. Cancer Cell & Ionizing Radiation
• Cancer cell multiply faster than normal cell
• DNA is primary target
• Double Strand breaks
>>> Reproductive Cell Death
13. • Injury to DNA is the primary mechanism by which
ionizing radiation kills cells .
– Most DNA damage is repaired
– Lethal double-strand breaks -persist (locally multiply
damaged sites (300) of about 15 to 20 nucleotides in size)
– Micronuclei formation
– Chromosome aberrations
– Cell death through loss of the reproductive integrity of the
cell's genome.
• Many biologic factors affect the relationship between
the amount of physical energy deposited, the extent of
DNA damage that is caused, the number of cells that
are killed, and the severity of the tissue response
14. • Radiation therapy is the art of using high
energy ionizing radiation to destroy malignant
tumors while being able to minimize damage
to normal tissue.
• To be practiced like a Religion
• SOPs
19. Brachytherapy :
Radioactive source loading
Temporary
Pre Loaded After loading
Remote
LDR HDR
Manual
Permanent
After Plan
Pre Plan
– Intracavitory / Luminal
– Interstitial
– Surface Mould
20. THE PAST
1895- 1920s : Seeding - X - Ray & Radium
1920 – 1930 : embryo Phase
1930 -1950 : Quisent phase : World War I & II
•Artificial Radioactivity,
•Development in Radar Technology
1950 – 1970 : Development Phase: Telecobalt & Linear
Acclelrator –
1980 – 2000 : Infancy
2000-2005 : Growth Phase
2005 – 2010 : Maturation Phase
2010 – 2015 : Flower
> 2015 : Fruits
21.
22. Marie Curie (1867 – 1934)
Born in Poland
University of Paris age 24
Discovered Radium 1898
t1/2 = 1602 years
24. Emil Grubbe (1875-1960)
: the World’s first Radiation Oncologist.
• medical student in Chicago
• convinced his professor to
allow him to irradiate a
cancer patient, a woman
named Rose Lee
• Ms. Lee benefited greatly
from Grubbe’s intervention,
demonstrating the potential
value of x-ray treatments.
25. Claude Regaud (1870-1940) : Paris
• recognized that treatment may be better tolerated
and more effective if delivered more slowly with
modest doses per day over several weeks.
26. Henri Coutard (1876-1950) Paris
• pioneered the use of fractionated
Radiotherapy in a wide variety of
tumors.
• Note, he reported impressive
results using this approach in
patients with locally advanced
laryngeal cancers. His seminal
1934 report of the outcome of
these patients is still quoted
today.
28. Gilbert Fletcher
• MD Anderson Cancer Center
• established optimal
treatment regimens in a
wide variety of tumor sites
including head and neck
cancers and cervical cancer.
29. Brief History of Radiation Therapy
Chronologic Milestones:
• 1895 W.K.Rontgen discovered X-Rays.
• The first patient was treated with radiation in 1896,
two months after the discovery of the X-ray.
• 1896 Becquerel reported natural radioactivity in
Uranium compounds.
• 1898 Marie and Pierre Curie isolated radium from
pitchblende.
• 1900 Villard reported that radium emitted alpha,
beta and gamma radiations.
• 1934 Frederic and Irene Joliot (Curie’s daughter)
discovered artificial radioactivity.
30.
31.
32. FIRST CURE OF CANCER BY X-RAYS
1899 - BASAL CELL CARCINOMA
X-rays were used to cure cancer very soon after their discovery
33. Natural radioactivity was discovered by Becquerel, who was awarded the Nobel Prize
in Physics in 1903 along with Marie and Pierre Curie "in recognition of the
extraordinary services they have rendered by their joint researches on the radiation
phenomena"
“One wraps a Lumiere photographic plate with a bromide emulsion in two sheets of very thick black paper, such that the plate does not become clouded upon
being exposed to the sun for a day. One places on the sheet of paper, on the outside, a slab of the phosphorescent substance, and one exposes the whole to
the sun for several hours. When one then develops the photographic plate, one recognizes that the silhouette of the phosphorescent substance appears in
black on the negative. If one places between the phosphorescent substance and the paper a piece of money or a metal screen pierced with a cut-out design,
one sees the image of these objects appear on the negative. One must conclude from these experiments that the phosphorescent substance in question emits
rays which pass through the opaque paper and reduces silver salts.” Paris 1896
Maltese crossHenri Becquerel Marie Curie
34. Radioisotopes also were soon being used
to treat and cure cancer.
Radium applicators were used for many
other conditions!
Radioactive plaques
and implants are still
in common use, for
example in prostate
implant seeds.
cure of cancer
by radium
plaque - 1922
35. • 1898 Becquerel’s vest-pocket skin erythema and reports
of x-ray ‘burns’.
• 1903 Bergonie and Tribondeau described radiosenstivity
of proliferating cells.
• 1930 Coutard proposed treatment fractionation.
• 1950 Paterson’s definition of Therapeutic Ratio: Normal
Tissue Tolerance/ Tumor Control Dose.
Chronologic Milestones
36. THE EVOLUTION OF RADIOTHERAPEUTIC
TECHNIQUES :EARLY CHALLENGES
• Detection of Ionizing Radiation
• Defining the Quality of Radiation
• Defining the Quantity of Radiation
• Understanding the Mechanism of Action of
Radiation
• Optimizing Radiation Delivery Equipments
37. THE EVOLUTION: Measuring Radiation Dose:
• Skin Erythema Dose.
• 1902 Holzknecht in Vienna developed the Chromoradiometer -
An apparatus once used for estimating radiation exposure by
means of the color changes produced in slides placed next to
the skin.
• 1904 Sabouraud and Noire in France modified Holzknecht’s
method to Pastille-dose technique using pastilles of barium
platinocyanide.
• 1913 Ionization current measurement developed in Paris, and
adopted in 1928 at the ICR as the standard unit “r”: x or gamma
radiation producing 1 e.s.u in 1 cc of air.
• 1953 at the ICR the ‘rad’ was introduced as the unit of absorbed
dose: equal to 100 ergs per gram.
• 1970 the rad was redefined in a metric system: the Gray: joules
absorbed per kg. 1 Gray = 100 rads.
38. THE EVOLUTION : Quality of Radiation
1913 Coolidge in the USA engineered the first successful X-ray
tube using hot-filament and Tungsten target.
1920 higher voltages X ray units with more powerful
transformers and rectifiers:
Contact therapy @ 50 KV,
Superficial @ 100-150 KV
Deep X-rays @ 200-400 KV.
Effect of added filtration.
Quality measured by HVL.
1933-1950 the evolution Megavolt era:
Van de Graaff electrostatic,
the Betatron,
the Cobalt units and
the Linear accelerator.
39. History of Particle Beam Therapy
1938 Neutron therapy by John Lawrence and R.S. Stone
(Berkeley)
1946 Robert Wilson suggests protons
1948 Extensive studies at Berkeley confirm Wilson
1954 Protons used on patients in Berkeley
1957 Uppsala duplicates Berkeley results on patients
1961 First treatment at Harvard (By the time the facility closed
in 2002, 9,111patients had been treated.)
1968 Dubna proton facility opens
1969 Moscow proton facility opens
1972 Neutron therapy initiated at MD Anderson (Soon 6 places in
USA.)
1974 Patient treated with pi meson beam at Los Alamos (Terminate
in 1981) (Starts and stops also at PSI and TRIUMF)
40. (Cont)
1975 St. Petersburg proton therapy facility opens
1975 Harvard team pioneers eye cancer treatment with protons
1976 Neutron therapy initiated at Fermilab. (By the time the
facility closed in 2003, 3,100 patients had been treated)
1977 Bevalac starts ion treatment of patients. (By the time the
facility closed in 1992, 223 patients had been treated.)
1979 Chiba opens with proton therapy
1988 Proton therapy approved by FDA
1989 Proton therapy at Clatterbridge
1990 Medicare covers proton therapy and Particle Therapy
Cooperative Group (PTCOG) is formed:
1990 First hospital-based facility at Loma Linda (California)
50. 1951 – First Cobalt machine
• Saskatoon, Saskatchewan
• London, Ontario
• Co 60
– t ½ = 5.26 years
– Gamma emitter
– Energy 1.25 MV
51. 1956, Henry Kaplan, MD
• The first patient to
receive radiation
therapy from the
medical linear
accelerator
• Stanford
• 2-year-old boy
with
retinoblastoma
52. History of Radiation Delivery
• Linear Accelerators: 1950 to present
– Traveling wave systems
– Standing wave systems
– Microtron
– Reflexotron
53. THE EVOLUTION OF RADIOTHERAPEUTIC
TECHNIQUES 1970 & 80s
Treatment Planning:
Central Axis % Depth Dose.
Plotting Isodose Curves.
Multiple Fields Cross-Fire.
Manual Patient Contouring and Manual Isodose
Curve Summation.
Computer Treatment Planning Central Axis and Off-
Axis.
Image Based 3-D Dose Distribution.
59. THE EVOLUTION OF RADIOTHERAPEUTIC
TECHNIQUES
Understanding the biology of Cancer:
The natural history of different tumors based
on cell types.
The importance of cancer staging.
Retrospective outcome studies and
prospective Clinical Trials.
Identifying Dose Response expectations.
61. • >1985 – CT scan for RT Planning , Involved Manual
Digitization of Contours only
• > 1990 – CT Scan Data was used for Target localization
& Contouring
– 3 D Rendering of Body contours and Tumour and normal
tissue Grids
– Beams Eye view
• > 1995
– 3D Planning
– 3D Conformal Bocks
• CD Scan data of Tissue Density used for RT calculation
• > 1998 - 3 D Conformal RT
• 2000 : Evolution of IMRT (Conceptualized in 1960s)
62. • Early 2000 IGRT – Cyber knife , non-isocentric
mount , Celing mounted KV Imaging and
advanced verification and repositioning
• 2005 IMRT as a routine
• With IGRT – Adaptive Radiotherpay need for
advanced Imaging
• CT on Rails or Onboard Mv/Kv Cones CT
imaging,
• Integration of ceiling mounted KV imaging
63. THE EVOLUTION OF RADIOTHERAPEUTIC
TECHNIQUES
Impact of Modern Technology:
Impact of Computer technology.
New Imaging technology.
Advances in Molecular biology.
The multidisciplinary approach to Cancer
treatment.
64. MODERN RADIOTHERAPEUTIC
TECHNIQUES
Image based treatment planning.
3-d conformal treatment planning.
Intensity Modulated Radiation Treatment
(IMRT).
Image Guided Radiation Treatment and
Adaptive Radiation Treatment.
Investigational: Proton and Particle Therapy.
65. Key Mile stone
• Use of CT Scan DICOM image for RT Planning
• 3 D rendering
• BEV
71. Multileaf Collimation
MicroMLC
• Maximum field size: 72 x 63 mm
•Number of leaves: 40 per side
•Leaf thickness: 1 mm
•Material: tungsten
• Maximum field size: 100 x 100
mm
•Number of leaves: 26 per side
•Leaf thickness: 5.5, 4.5, 3 mm
•Material: tungsten
82. Brachytherapy :
Radioactive source loading
Temporary
Pre Loaded After loading
Remote
LDR HDR
Manual
Permanent
After Plan
Pre Plan
– Intracavitory / Luminal
– Interstitial
– Surface Mould
95. Future : KMIO RO
• KMIO has been granted a status of State
cancer Institute : Apex Institution in the State
of Karnataka to forsee cancer related activities
in the region.
97. >2015
Radiation
Oncology Block
Fully Automated ,
Paperless
environment
Sanctione
d
Equipments Number
State of the Art
High energy Linear Accelerators
4 IMRT – Advanced rotational
IGRT
4D / 6D
Advanced tumor tracking
FFF
SRS/SRT
Whole body SBRT
HDR Brachytherapy 2 IR / Cobalt
Virtual Widebore CT Simulators 2
Permanent Implant Brachytherapy
suit with advanced planning system
1 Capable of handling Iodine seed –
BARC / Imported
Intra operative Electronic
Brachytherapy / Electorns suit
1
Advanced Doismetry equipments Set
98. Future - Research
• Cell biology - understand effects of ionizing radiation on cells,
tumors, and normal tissues.
• molecular cancer biology - clinical decision-making in oncology
• development of novel biology-driven strategies in the
multidisciplinary clinical environment.
– Molecular pathology of tumors - basis for improved
treatment stratification in oncology .
– Molecular pathophysiology - manifestation of radiation
sequelae in normal tissues .
– Molecular imaging - staging , biologic characterization of
tumors, and for determination of target volumes in
radiation oncology, including new approaches such as dose
painting.
– Molecular targeting in radiotherapy - enhancing the
therapeutic gain of the treatment.
123. Grenz Rays
Megavoltage
Orthovoltage
Superficial Therapy
Contact Therapy
20 KeV
50 KeV
150 KeV
500 KeV
1-25 MeV Major improvements in RT
during the mid-1900s came
from improved penumbra
and decreased skin dose
associated with higher
energy x-rays, cobalt, and
high energy photons.
More recently conformal
RT, IMRT, IGRT,
Gammaknife, Cyberknife,
tomotherapy, SRS, SRT,
protons, heavy ions, etc.
have added considerable
variety to the choices for
physical radiation delivery
and present radiobiological
challenges.